Weihai Pharmaceutical and Medical Device Industry Association and Korea-China Science and Technology Service Association discuss the 2024 China-Korea (Weihai) Medical Industry Integration Development Conference

On November 17, Lee Jae-je, President of the Korea-China Science and Technology Service Association, visited Weihai and had an in-depth discussion with Zhang Lin, Vice President of the Weihai Pharmaceutical and Medical Device Industry Association, on the conference plan for the 2024 China-Korea (Weihai) Medical Industry Integration Development Conference, aiming to integrate the pharmaceutical and medical device resources of China and South Korea and jointly promote the high-quality development of the pharmaceutical and medical device industry. Important leaders of the Weihai Global Partner Business Center and the Weihai High-tech Zone Commerce Bureau attended the symposium and provided valuable suggestions for the holding of this conference.

During this important meeting, the two sides had a detailed discussion on the agenda of the "2024 China-Korea (Weihai) Medical Industry Integration Development Conference" to be held from December 16 to 18, 2024. The conference is expected to have about 130 important guests, including outstanding corporate representatives, experts and professors, heads of investment institutions and media representatives.

The conference will be held at the Golden Bay International Hotel in Weihai, with the theme of "Innovation, Technology and Integration", aiming to promote the integration and development of China and South Korea in the field of medical industry through in-depth exchanges and cooperation. The conference will invite many heavyweight guests including Park Tae-kwon, Vice President of the Korean Constitutional Association, and Long Hongze, former First Deputy Minister of the Ministry of Science and Technology of South Korea.

During the discussion at the conference, Zhang Lin, vice president of the Weihai Pharmaceutical and Medical Device Industry Association, emphasized the importance of this conference to Weihai's pharmaceutical and medical device industry. Weihai has positioned the pharmaceutical and medical device industry as the "No. 1 industry" and is committed to building a "domestic demonstration zone for high-quality development of pharmaceutical and medical devices with significant influence and competitiveness" and a "China Medical Device City". The convening of this conference will provide new opportunities and impetus for the development of Weihai's pharmaceutical and medical device industry. It will also make an important contribution to the healthy development of Weihai's foreign trade and foreign trade.

Li Zaijie, president of the Korea-China Science and Technology Service Association, expressed his appreciation for the preparations for the conference and looked forward to the successful holding of the conference in the future. At the same time, this conference will further strengthen the cooperation between China and South Korea in the field of medical industry. He said that the Korea-China Science and Technology Service Association will fully support the holding of the conference and actively promote exchanges and cooperation between Korean companies and Weihai's pharmaceutical and medical device industry.

The two sides also discussed the specific agenda of the conference, including the signing of a project cooperation agreement between Chinese and Korean companies, the authorization ceremony of the China-Korea technology project cooperation platform, corporate roadshows, and docking exchanges between Chinese and Korean pharmaceutical and medical device companies. In addition, the conference will also arrange important exchange activities such as visiting Weigao Group's factory, exhibition hall and Gaoqu Medical Equipment Industrial Park.

This meeting laid a solid foundation for the successful holding of the "2024 China-Korea (Weihai) Medical Industry Integration Development Conference". Both the Chinese and Korean associations expressed that they will work together to improve the details of the conference to ensure that the conference can be held smoothly and successfully, and contribute to the cooperation and development of the medical industries of China and South Korea.